SG
StoneX Group’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,185
| Closed | -$227K | – | 417 |
|
|
2023
Q3 | $227K | Sell |
7,185
-242
| -3% | -$7.65K | 0.13% | 250 |
|
|
2023
Q2 | $303K | Buy |
7,427
+42
| +0.6% | +$1.71K | 0.17% | 174 |
|
|
2023
Q1 | $275K | Sell |
7,385
-239
| -3% | -$8.91K | 0.16% | 196 |
|
|
2022
Q4 | $266K | Buy |
+7,624
| New | +$266K | 0.04% | 329 |
|
|
2022
Q2 | – | Sell |
-7,515
| Closed | -$546K | – | 670 |
|
|
2022
Q1 | $546K | Sell |
7,515
-815
| -10% | -$59.2K | 0.05% | 291 |
|
|
2021
Q4 | $985K | Sell |
8,330
-1,671
| -17% | -$198K | 0.11% | 175 |
|
|
2021
Q3 | $1.34M | Sell |
10,001
-1,791
| -15% | -$240K | 0.19% | 113 |
|
|
2021
Q2 | $1.91M | Sell |
11,792
-1,085
| -8% | -$176K | 0.28% | 71 |
|
|
2021
Q1 | $1.03M | Sell |
12,877
-990
| -7% | -$79.4K | 0.19% | 107 |
|
|
2020
Q4 | $754K | Sell |
13,867
-515
| -4% | -$28K | 0.17% | 130 |
|
|
2020
Q3 | $286K | Sell |
14,382
-100
| -0.7% | -$1.99K | 0.09% | 238 |
|
|
2020
Q2 | $304K | Sell |
14,482
-500
| -3% | -$10.5K | 0.12% | 212 |
|
|
2020
Q1 | $183K | Hold |
14,982
| – | – | 0.1% | 229 |
|
|
2019
Q4 | $220K | Sell |
14,982
-1,335
| -8% | -$19.6K | 0.09% | 272 |
|
|
2019
Q3 | $218K | Sell |
16,317
-535
| -3% | -$7.15K | 0.14% | 226 |
|
|
2019
Q2 | $276K | Sell |
16,852
-700
| -4% | -$11.5K | 0.18% | 180 |
|
|
2019
Q1 | $300K | Sell |
17,552
-443
| -2% | -$7.57K | 0.23% | 156 |
|
|
2018
Q4 | $246K | Sell |
17,995
-1,803
| -9% | -$24.6K | 0.24% | 164 |
|
|
2018
Q3 | $567K | Sell |
19,798
-697
| -3% | -$20K | 0.42% | 78 |
|
|
2018
Q2 | $561K | Buy |
20,495
+875
| +4% | +$24K | 0.48% | 68 |
|
|
2018
Q1 | $414K | Buy |
19,620
+1,255
| +7% | +$26.5K | 0.4% | 89 |
|
|
2017
Q4 | $353K | Buy |
+18,365
| New | +$353K | 0.37% | 103 |
|